| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5987257 | The Journal of Heart and Lung Transplantation | 2015 | 31 Pages |
Abstract
WHO Group II PH is prevalent and identifies HF patients at risk for adverse outcomes. Ongoing knowledge of hemodynamic variables may allow for more effective treatment strategies to reduce the morbidity of this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Raymond L. MD, Amresh MD, William T. MD, Philip B. MD, JoAnn MD, Alan B. MD, Robert C. MD, Jordan MS, Jay MD,